NEW YORK, NY--(Marketwired - February 27, 2017) - The Trout Group, the leading global investor relations and strategic advisory firm servicing the life sciences industry, today announced an upcoming KOL Trout Talk featuring Dr. Philip D. Greenberg (Phil), Professor of Medicine in Oncology and Immunology - University of Washington. Dr. Greenberg's talk, "Engineering T Cells to be Effective in Tumor Therapy" will be webcast live on February 28th at 11:15AM EST and can be accessed at trouttalk.troutgroup.com.
Trout is an investor relation and strategic advisory firm that provides targeting, outreach and market intelligence services to medical and life science sectors.